ATG4B and neoplasm: High ATG4B was positively related to elevated mortality in patients with advanced tumors, including differentiated tumor cells (moderate and poor: AHR = 5.17, p < 0.001, Table 4), AJCC stage III + IV (AHR = 4.37, p < 0.001), large tumor size T3 + T4 (AHR = 3.73, p < 0.001); lymph node invasion N1 + N2 stage (AHR = 4.69, p = 0.001).